The discovery of carboline analogs as potent MAPKAP-K2 inhibitors
Authors:
- Jiang-Ping WuJWJiang-Ping Wu
- Ji WangJWJi Wang
- Asitha AbeywardaneAAAsitha Abeywardane
- Denise AndersenDADenise Andersen
- Michel EmmanuelMEMichel Emmanuel
- Elda GautschiEGElda Gautschi
- Daniel R. GoldbergDGDaniel R. Goldberg
- Mohammed A. KashemMKMohammed A. Kashem
- Susan LukasSLSusan Lukas
- Wang MaoWMWang Mao
- Leslie MartinLMLeslie Martin
- Tina MorwickTMTina Morwick
- 1 August 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (16) , 4664-4669
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Molecular basis of MAPK-activated protein kinase 2:p38 assemblyProceedings of the National Academy of Sciences, 2007
- Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammationCurrent Opinion in Pharmacology, 2004
- Catalysis and Function of the p38α·MK2a Signaling ComplexBiochemistry, 2004
- Fluorescence Polarization Assays in Signal Transduction DiscoveryCombinatorial Chemistry & High Throughput Screening, 2003
- The Non-Diaryl Heterocycle Classes of p38 MAP Kinase InhibitorsCurrent Topics in Medicinal Chemistry, 2002
- Distinct Cellular Functions of MK2Molecular and Cellular Biology, 2002
- Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical CandidateJournal of Medicinal Chemistry, 2002
- The stress-activated protein kinase pathwaysCellular and Molecular Life Sciences, 1999
- Mitogen-activated protein kinase pathwaysCurrent Opinion in Cell Biology, 1997
- Interleukin-1Clinical Infectious Diseases, 1984